Biocon Biologics appoints Deepali Naair as Global Head - Brand & Corporate Communications Ruchika Sharma23 July 2025 1:06 PM ISTBengaluru: Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited, has announced the...
Biocon Biologics launches Nepexto in Australia Ruchika Sharma23 July 2025 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced it has launched...
Biocon targets launch for generic Wegovy in India by 2027 Ruchika Sharma17 July 2025 5:20 PM ISTBiopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster weight-loss drug Wegovy in India by...
Biocon Biologics expands biosimilar insulin portfolio with USFDA nod of Kirsty Ruchika Sharma16 July 2025 11:30 AM ISTKarnataka: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received approval...
Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer Ruchika Sharma10 July 2025 3:13 PM ISTBangalore: Biocon has announced the appointment of Ekta Agarwal as the Interim Company Secretary and Compliance Officer (being Key Managerial...
No connection between COVID, vaccine and heart attacks, Karnataka expert committee finds amid Siddaramaiah controversy Ruchika Sharma8 July 2025 4:55 PM ISTBengaluru: An expert committee tasked with investigating the recent cases of heart attack deaths in Karnataka has put to rest the growing...
Biocon Biologics gets marketing nods in UK for Vevzuo, Evfraxy Ruchika Sharma7 July 2025 11:12 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received marketing...
COVID-19 Vaccine and Heart Attack: Biocon Chief, Karnataka CM get into war of words Ruchika Sharma5 July 2025 5:03 PM ISTBengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on thursday over...
Biocon Biologics gets EU nod for bone disease treatments, including Osteoporosis, giant cell tumour of bone Ruchika Sharma3 July 2025 11:29 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the...
Biocon Biologics Yesafili gets Health Canada nod for eye diseases Ruchika Sharma27 Jun 2025 11:36 AM ISTYESAFILI is the first biosimilar to EYLEA to be approved by Health Canada.
Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India Dr. Divya Colin25 Jun 2025 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO),...
Biocon concludes Rs 4500 crore equity fundraise through QIP Ruchika Sharma21 Jun 2025 11:30 AM ISTBengaluru: Biocon Limited, a global biopharmaceutical company, has announced the successful completion of a Qualified Institutions...
